SCHEMBL18949024

SCHEMBL18949024

COC(=O)NC(C(=O)N1C[C@@H](F)C[C@H]1C)C(C)C

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.40
CYP3A4 P08684 6/20 0.39
CYP2C9 P11712 5/20 0.38
KCNH2 Q12809 2/20 0.38
NR1I2 O75469 1/20 0.38
ABCB11 O95342 1/20 0.38
OPRK1 P41145 1/20 0.38
PEPD P12955 1/20 0.38
XPNPEP1 Q9NQW7 1/20 0.38
DPP4 P27487 3/20 0.37
DPP8 Q6V1X1 2/20 0.37
DPP9 Q86TI2 2/20 0.37
ABL1 P00519 1/20 0.35
BCR P11274 1/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2D6 P10635 1/20 0.35
TSHR P16473 1/20 0.33
CAPN1 P07384 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10140557 1.00 PIN1 (0.40) PIN1CYP3A4CYP2C9KCNH2NR1I2
SCHEMBL3268607 1.00 PIN1 (0.40) PIN1CYP3A4CYP2C9KCNH2NR1I2
SCHEMBL15765617 1.00 PIN1 (0.40) PIN1CYP3A4CYP2C9KCNH2NR1I2
SCHEMBL15765653 1.00 PIN1 (0.40) PIN1CYP3A4CYP2C9KCNH2NR1I2
SCHEMBL12402532 1.00 PIN1 (0.40) PIN1CYP3A4CYP2C9KCNH2NR1I2
SCHEMBL3265347 1.00 PIN1 (0.40) PIN1CYP3A4CYP2C9KCNH2NR1I2
SCHEMBL15478299 0.86 CYP2C9 (0.40) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL18949011 0.86 CYP2C9 (0.40) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL10119246 0.85 PIK3CD (0.40) PIN1CYP3A4CYP2C9KCNH2NR1I2
SCHEMBL9972557 0.85 PIK3CD (0.40) PIN1CYP3A4CYP2C9KCNH2NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9676802-B2 Hepatitis C virus inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2017-06-13 US disclosed